SCHEMBL25311385

SCHEMBL25311385

O=C(O)Nc1cn2c(Br)cccc2n1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 8/20 0.40
JAK2 O60674 3/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
MAP3K5 Q99683 1/20 0.37
TYK2 P29597 2/20 0.36
NTRK1 P04629 1/20 0.35
MAPT P10636 1/20 0.35
GAA P10253 1/20 0.35
EPHB3 P54753 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17987159 0.82 JAK1 (0.59) JAK1JAK2TYK2
SCHEMBL19762846 0.79 JAK1 (0.40) JAK1NPC1RAB9AMAP3K5GAA
SCHEMBL25311850 0.78 LRRK2 (0.54)
SCHEMBL25311848 0.78 LRRK2 (0.54)
SCHEMBL22971273 0.78 LRRK2 (0.54)
SCHEMBL3306389 0.76 PTGS1 (0.51) NPC1TP53RAB9AMAPTGAA
SCHEMBL5353113 0.73 JAK1 (0.42) JAK1JAK2NPC1TP53RAB9A
SCHEMBL29993826 0.71 GAA (0.42) JAK2NPC1RAB9ANTRK1MAPT
SCHEMBL913680 0.71 PTGS1 (0.58) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL2085478 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111892592-B JAK kinase inhibitors and uses thereof 江苏柯菲平医药股份有限公司 2023-09-19 CN disclosed
WO-2023138550-A1 CYCLOPROPANAMIDE-CONTAINING COMPOUND AND USE THEREOF 盛世泰科生物医药技术(苏州)有限公司 2023-07-27 WO disclosed
CN-114075189-A Five-membered heterocyclic acene ring compound and preparation method and medical application thereof 南京柯菲平盛辉制药有限公司 2022-02-22 CN disclosed
CN-111892592-A JAK kinase inhibitors and uses thereof 江苏柯菲平医药股份有限公司 2020-11-06 CN disclosed
CN-107428749-B Substituted imidazo [1,2- α ] pyridin-2-ylamine compounds, pharmaceutical compositions and methods of use thereof 上海复旦张江生物医药股份有限公司 2020-07-24 CN disclosed